Although acute exposure of the heart to angiotensin (Ang II) produces physiological cardiac
hypertrophy and chronic exposure results in pathological hypertrophy, the signal …

Angiotensin II (Ang II) is formed by the action of angiotensin-converting enzyme (ACE) in the
renin–angiotensin system. This hormone is known to induce cardiac hypertrophy and heart …

Heart failure is the common concluding pathway for a majority of cardiovascular diseases
and is associated with cardiac dysfunction. Since heart failure is invariably preceded by …

The renin-angiotensin system (RAS) is one of major neuro-endocrine entity which is
intimately involved in regulating the cellular functions and metabolic activities in the body …

An increase in the occurrence of different infectious and chronic diseases as well as aging
population has resulted in poor human health and decline in the quality of life all over the …

Various protein kinases including protein kinase A (PKA), Ca2+-calmodulin kinase (CaMK),
phosphoinositide 3-kinase (PI3K), protein kinase C (PKC) and mitogen-activated protein …

Background: The prevention of drug-induced cardiotoxicity is a complicated challenge
facing healthcare providers during the last few decades. This challenge is raised from the …

خلفية الموضوع: الوقاية من السُّمية القلبية الناتجة عن استعمال الادوية هي مهمة معقدة تواجه القائمين
على الرعاية الصحية خلال العقود الأخيرة. هذا التحدي قد ينبع من عدم الوضوح في تعريف السُّمية …‎

Цель исследования-определить уровень ангиотензина II в раннем постинфарктном
периоде, а также его взаимосвязь со структурными параметрами сердца и роль …

The National Cancer Institute defines cardiotoxicity as any form of toxicity that influences the
heart, including direct effects on the organ and changes in hemodynamic flow or any form of …